Hemagglutinin-specific cytotoxic T-cell response during influenza infection.

Viral myocarditis. A review. Am J Pathol (1980) 3.33

On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci U S A (1996) 2.55

Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. J Exp Med (1978) 2.54

Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells. Infect Immun (1980) 1.71

Specificity of cytotoxicity T cells directed to influenza virus hemagglutinin. J Exp Med (1979) 1.64

Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus. J Exp Med (1981) 1.64

Recognition of viral glycoproteins by influenza A-specific cross-reactive cytolytic T lymphocytes. J Exp Med (1980) 1.58

The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection. J Exp Med (1979) 1.51

Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene. Proc Natl Acad Sci U S A (1979) 1.50

The human cytotoxic T cell response to influenza A vaccination. Clin Exp Immunol (1981) 1.37

Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli. J Exp Med (1985) 1.37

T-cell populations specifically depleted of alloreactive potential cannot be induced to lyse H-2-different virus-infected target cells. J Exp Med (1978) 1.36

Evidence that cytotoxic T cells are part of the host's response to influenza pneumonia. J Exp Med (1978) 1.25

Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro. Infect Immun (1978) 1.19

Influenzal pneumonia: early appearance of cross-reactive T cells in lungs of mice primed with heterologous type A viruses. Immunology (1978) 1.15

Cytomegalovirus-specific cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers. Infect Immun (1981) 1.03

Hemagglutinin-specific complement-dependent cytolytic antibody response to influenza infection. J Exp Med (1978) 1.02

Diminished T-cell response to influenza virus in aged mice. Immunology (1983) 1.01

Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine. Infect Immun (1980) 0.97

Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs. J Virol (1987) 0.97

Regional T- and B-cell responses in influenza-infected ferrets. Infect Immun (1978) 0.93

Evidence for two T-helper populations with distinct specificity in the humoral response to influenza A viruses. Immunology (1982) 0.92

Immune responses of cattle to Theileria parva (East Coast fever): specificity of cytotoxic cells generated in vivo and in vitro. Immunology (1983) 0.87

Persistence of influenza as an immunogen in pulmonary antigen-presenting cells. Infect Immun (1983) 0.81

Anti-influenza human T killer cells present an intertypic activity anti-A and -B type viruses in a secondary reaction in vitro. Clin Exp Immunol (1983) 0.75

The influenza virus: Antigenic composition and immune response. Postgrad Med J (1979) 0.75

Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J Exp Med (1977) 5.20

Heterogeneity of the cytotoxic response of thymus-derived lymphocytes after immunization with influenza viruses. Proc Natl Acad Sci U S A (1977) 3.02

Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 15.16

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44

In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother (1972) 11.05

Evaluation of accuracy of multitest micromethod system for identification of Enterobacteriaceae. Appl Microbiol (1971) 10.28

Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med (1988) 9.10

Clinical utility of thoracoscopy. Chest (1992) 6.34

Practical method for isolation of anerobic bacteria in the clinical laboratory. Appl Microbiol (1971) 5.45

Identification of members of the family Enterobacteriaceae by the R-B system. Appl Microbiol (1970) 5.27

Comparison of three blood culture media for recovery of anaerobic bacteria. Appl Microbiol (1973) 5.22

Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis (1997) 5.13

Early clinical and laboratory indicators of acute dengue illness. J Infect Dis (1997) 5.00

Anaerobic bacteremia. Mayo Clin Proc (1972) 4.79

Microwave oven for melting laboratory media. J Clin Microbiol (1978) 4.33

Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical card. J Clin Microbiol (1980) 4.28

Evaluation of reagent-impregnated strips for identification of Enterobacteriaceae. Am J Med Technol (1971) 3.60

Isolation and indentification of anaerobic bacteria in the clinical laboratory. A 2-year experience. Mayo Clin Proc (1974) 3.54

Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis (1988) 3.52

Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science (1988) 3.44

Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16

Immunopathogenesis of Dengue hemorrhagic fever. Virology (1999) 3.16

Klebsiella in faecal flora of renal-transplant patients. Lancet (1970) 3.14

Evaluation of the enterotube system for identification of members of the family Enterobacteriaceae. Appl Microbiol (1971) 3.11

Evaluation of enrichment, storage, and age of blood agar medium in relation to its ability to support growth of anaerobic bacteria. J Clin Microbiol (1976) 3.09

Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis (1999) 2.96

Linkage between the poly-L-lysine gene and the locus controlling the major histocompatibility antigens in strain 2 guinea pigs. Proc Natl Acad Sci U S A (1970) 2.89

Biochemical and clinical characteristics and antibiotic susceptibility of atypical Enterobacter cloacae. Appl Microbiol (1969) 2.87

Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis (1989) 2.86

Evaluation of the Auxotab Enteric 1 System for identification of Enterobacteriaceae. Appl Microbiol (1972) 2.85

In vitro studies of piperacilin, a new semisynthetic penicillin. Antimicrob Agents Chemother (1978) 2.82

Clinical isolation of Yersinia enterocolitica: cold temperature enrichment. J Clin Microbiol (1975) 2.76

Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr (1977) 2.66

Genetic control of immune responsiveness to a glutamic acid, alanine, tyrosine copolymer in mice. I. Linkage of responsiveness to H-2 genotype. J Immunol (1971) 2.60

A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J Infect Dis (1977) 2.55

Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species. J Immunol (1999) 2.54

API and Minitek systems in identification of clinical isolates of anaerobic gram-negative bacilli and Clostridium species. J Clin Microbiol (1979) 2.54

Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med (1983) 2.53

Epidemiologic significance of Klebsiella pneumoniae. A 3-month study. Mayo Clin Proc (1971) 2.51

Prevalence of serotypes of Salmonella. Appl Microbiol (1969) 2.50

Clinical and bacteriologic studies of anaerobic gram-positive cocci. Mayo Clin Proc (1972) 2.48

Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol (1990) 2.47

Diverticula of the Small Bowel. Ann Surg (1934) 2.44

Heamophilus vaginalis (Corynebacterium vaginal): method for isolation and rapid biochemical identification. Health Lab Sci (1977) 2.37

Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest (1991) 2.37

Bacteroides bacteremia. Minn Med (1970) 2.36

Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J Virol (1996) 2.35

Bacterial (suppurative) arthritis in the adult. J Bone Joint Surg Am (1970) 2.26

Evaluation of the MS-2 system for rapid identification of Enterobacteriaceae. J Clin Microbiol (1980) 2.26

Rapid identification and antimicrobial susceptibility testing of gram-negative bacilli from blood cultures by the AutoMicrobic system. J Clin Microbiol (1981) 2.24

Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.23

Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia. J Immunol (1981) 2.19

HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens (2002) 2.18

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med (1985) 2.12

Clinical evaluation of a lysis-centrifugation technique for the detection of septicemia. JAMA (1983) 2.12

Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J Virol (1998) 2.10

Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology. Cancer Res (1988) 2.06

Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method. J Clin Microbiol (1986) 2.05

Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods. J Clin Microbiol (1979) 2.04

Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. J Immunol (1981) 2.04

High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis (1999) 2.02

Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest (1989) 2.01

Clinical evaluation of the AutoMicrobic system Yeast Biochemical Card for rapid identification of medically important yeasts. J Clin Microbiol (1981) 1.94

Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol (2001) 1.92

Histocompatibility type and immune responsiveness in random bred Hartley strain guinea pigs. J Exp Med (1970) 1.90

Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med (1977) 1.90

Cytotoxic T lymphocyte response to murine cytomegalovirus infection. Nature (1978) 1.89

Brain abscess with Corynebacterium hemolyticum: report of a case. Am J Clin Pathol (1971) 1.87

Non-radioactive single strand conformation polymorphism (SSCP) using the Pharmacia 'PhastSystem'. Nucleic Acids Res (1991) 1.86

Influenza virus infection in nude mice. J Infect Dis (1976) 1.85

Nosocomially acquired bacteriuria due to Proteus rettgeri and Providencia stuartii. Am J Clin Pathol (1973) 1.83

Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis (1999) 1.82

Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance. JAMA (1970) 1.80

An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. J Virol (1991) 1.80

Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol (1999) 1.79

Summary of clinical trials of inactivated influenza vaccine - 1978. Rev Infect Dis (1983) 1.79

Rapid diagnosis of dengue viremia by reverse transcriptase-polymerase chain reaction using 3'-noncoding region universal primers. Am J Trop Med Hyg (1997) 1.75

In vitro susceptibility of gram-negative bacilli to gentamicin. Mayo Clin Proc (1970) 1.72

Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol (1988) 1.71

Cell-adhesive motif in region II of malarial circumsporozoite protein. Science (1990) 1.69

Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. J Exp Med (1989) 1.68

An analgesia circuit activated by cannabinoids. Nature (1998) 1.68

Anti-Salmonella agglutinins in chronic active liver disease. Lancet (1971) 1.67

Host defense mechanisms against Herpes simplex virus. I. Control of infection in vitro by senstized spleen cells and antibody. Infect Immun (1973) 1.67

Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Virol (1984) 1.66

Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus. J Exp Med (1981) 1.64

Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis (1983) 1.64

A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6. J Virol (1992) 1.63

Expression of yeast apurinic/apyrimidinic endonuclease (APN1) protects lung epithelial cells from bleomycin toxicity. Am J Respir Cell Mol Biol (2001) 1.63

Molecular evolution of dengue type 2 virus in Thailand. Am J Trop Med Hyg (1998) 1.63

Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl (1994) 1.61

The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice. J Immunol (1978) 1.60

In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Antimicrob Agents Chemother (1977) 1.60

Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. J Biol Stand (1980) 1.59

High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg (1993) 1.56

Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes. J Virol (1989) 1.55

Enhanced immunogenicity of chemically-coated syngeneic tumor cells. Proc Natl Acad Sci U S A (1971) 1.55

120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest (1992) 1.53

Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens. Proc Natl Acad Sci U S A (1977) 1.53

In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration. Mayo Clin Proc (1970) 1.53